Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05623306 · ClinicalTrials.gov registry record · NA

SEEG-Guided DBS for OCD

A NA study of Obsessive - Compulsive Disorder, sponsored by Casey H. Halpern, M.D..

Recruiting
Registry status
NA
Development phase
10
Enrollment target
2
Study locations

NCT05623306 is a NA study of Obsessive - Compulsive Disorder that is actively recruiting participants, run by Casey H. Halpern, M.D.. The registered enrollment target is 10 participants, below the 2,065-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05623306, a NA study of Obsessive - Compulsive Disorder, is actively recruiting participants, sponsored by Casey H. Halpern, M.D..

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
2
Study locations

Study Summary

This is a multi-site, double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open label stimulation for an additional 6 months. The study will be conducted in 3 stages: Stage 1 will consist of SEEG brain mapping and optimization of stimulation parameters. Stage 2 will consist of DBS surgery and further optimization of stimulation parameters. Stage 3 will be randomized, crossover treatment, followed by open label treatment.

Conditions Studied

Obsessive - Compulsive Disorder

Interventions

  • DEVICE PMT Stereoencephalography (SEEG)
  • DEVICE Vercise Genus™ Deep Brain Stimulation (DBS) System or Percept™ PC Neurostimulation System

Study Locations (2)

California

  • Stanford University - Stanford

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2023-04-13
Est. Completion 2027-01-01
Phase NA

Sponsor

Casey H. Halpern, M.D.

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05623306

The ClinicalTrials.gov registry entry for NCT05623306 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,065-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (100% lower). The listed sponsor is Casey H. Halpern, M.D., which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 2 interventions - of which PMT Stereoencephalography (SEEG) is the first listed.

NCT05623306 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05623306 about?

NCT05623306 is a clinical study titled "SEEG-Guided DBS for OCD". This is a multi-site, double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open label stimulation for an additional 6 months. The study will be conducted in 3 stages: Stage 1 will consist of SEEG brain mapping and optimization of sti...

What is the current status of trial NCT05623306?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-04-13. Estimated completion is 2027-01-01.

What conditions does trial NCT05623306 study?

This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.

What interventions are being tested in trial NCT05623306?

The interventions under investigation include: PMT Stereoencephalography (SEEG) (DEVICE), Vercise Genus™ Deep Brain Stimulation (DBS) System or Percept™ PC Neurostimulation System (DEVICE).

Who is sponsoring clinical trial NCT05623306?

This trial is sponsored by Casey H. Halpern, M.D., which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05623306 being conducted?

This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obsessive - Compulsive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obsessive - Compulsive Disorder

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.